Results 31 to 40 of about 345,374 (311)

How to Achieve Standardization? Diluted Russell Viper Venom Test for Lupus Anticoagulant Detection in a Chinese Female Population

Clinical and Applied Thrombosis/Hemostasis, 2021
On an international scale, guidelines and proposals for lupus anticoagulant detection have been published over the last 20 years, but until now, standardization has not been completely realized. The aim of this study was to evaluate the different ways of
Feng Lu, Qingkai Dai, Yuefang Wang, Xia Zhang, Ge Zhang   +4 more
doaj   +1 more source

Lupus anticoagulant is frequent in patients with Covid‐19

Journal of Thrombosis and Haemostasis, 2020
Patients hospitalized for Covid-19 severe infection are more prone to excessive coagulation activation leading to thrombotic events. Tang et al.1 discussed the importance of high D-dimer and Fibrin degradation product level to determine the patient ...
I. Harzallah, A. Debliquis, B. Drénou
semanticscholar   +1 more source

Implications of Antiphospholipid and Antineutrophilic Cytoplasmic Antibodies in the Context of Postinfectious Glomerulonephritis. [PDF]

, 2017
While antineutrophil cytoplasmic antibody (ANCA) positivity has been documented in some patients with postinfectious glomerulonephritis (PIGN) and is associated with more severe disease, antiphospholipid antibodies (APA) are not known to be a common ...
Butani, Lavjay, Leifer, Daniel
core   +4 more sources

Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19)

JAMA Network Open, 2020
This cohort study assesses the prevalence of lupus anticoagulant (LA) positivity in patients with coronavirus disease 2019 (COVID-19) and examines the association of LA positivity with patient outcomes.
M. Reyes Gil, M. Barouqa, James M Szymanski, Jesus D Gonzalez-Lugo, Shafia Rahman, H. Billett   +5 more
semanticscholar   +1 more source

Influence of vitamin K antagonist treatment on activated partial thromboplastin time [PDF]

, 2015
A
Devreese, Katrien, MULLIEZ, SYLVIE, Van den Bogaert, Julie   +2 more
core   +2 more sources

Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis

Journal of Thrombosis and Haemostasis, 2020
The laboratory detection of lupus anticoagulants (LA) in anticoagulated patients represents a challenge and there is no consensus on the types of assays/procedures to be adopted.
A. Tripodi, H. Cohen, K. Devreese
semanticscholar   +1 more source

Transmission of lupus anticoagulant by allogeneic stem cell transplantation

Revista Brasileira de Hematologia e Hemoterapia, 2014
Passive transmission of autoimmune diseases by allogeneic stem cell transplantation is rare and is ascribed to passive transfer of memory B-cells from donor to recipient. We hereby report a case of transmission of an asymptomatic lupus anticoagulant from
Mira Romany Massoud, Basem M. William, Katrina Harrill, Brenda Wimpfheimer Cooper, Marcos de Lima, Alvin H. Schmaier   +5 more
doaj   +1 more source

Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort [PDF]

, 2015
Objectives. The anti-dsDNA antibodies are a marker for Systemic Lupus Erythematosus (SLE) and 70–98% of patients test positive. We evaluated the demographic, clinical, laboratory, and therapeutical features of a monocentric SLE cohort according to the ...
Alessandri, Cristiano, Ceccarelli, Fulvia, Conti, Fabrizio, Marocchi, Elisa, Massaro, Laura, Miranda, Francesca, Perricone, Carlo, Spinelli, FRANCESCA ROMANA, Truglia, Simona, Valesini, Guido   +9 more
core   +1 more source

Tetra positive thrombotic antiphospholipid syndrome: Major contribution of anti‐phosphatidyl‐serine/prothrombin antibodies to lupus anticoagulant activity

Journal of Thrombosis and Haemostasis, 2020
The concurrent presence of lupus anticoagulant, anticardiolipin, and anti β2‐glycoprotein I antibodies (triple positive profile) identifies patients at high risk of thromboembolic events.
M. Cattini, E. Bison, E. Pontara, Chun-Yan Cheng, G. Denas, V. Pengo   +5 more
semanticscholar   +1 more source

High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice [PDF]

, 2011
Background: We have empirically noted that many physicians routinely request anti-phospholipid antibodies (aPL) without a correct clinical indication. The aim of this study was to evaluate retrospectively whether aPL testing at our Thrombosis Centre was ...
Barcellona D, Mameli A, Marongiu F, Vannini ML   +3 more
core   +1 more source